The Onset of Monoclonal and Oligoclonal Gammopathies Is a Good Prognostic Factor after Allogeneic Stem Cell Transplantation

Acta Haematol. 2019;141(1):7-11. doi: 10.1159/000493416. Epub 2018 Nov 15.

Affiliations

¹ Hematology Division, Pisa University Hospital, Pisa, Italy, [email protected].
² Dudakov Lab, Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA, [email protected].
³ Hematology Division, Pisa University Hospital, Pisa, Italy.
⁴ Biostatistical Consulting, Pisa University Hospital, University of Pisa, Pisa, Italy.

PMID: 30439709
DOI: 10.1159/000493416

No abstract available

MeSH terms

Disease-Free Survival
Female
Hematopoietic Stem Cell Transplantation / adverse effects*
Hematopoietic Stem Cells / cytology
Hematopoietic Stem Cells / metabolism
Humans
Kaplan-Meier Estimate
Male
Paraproteinemias / etiology*
Paraproteinemias / mortality
Paraproteinemias / pathology
Prognosis
Transplantation, Homologous